Regent’s Park raises £5,620 for The Royal Marsden Hospital Cancer Charity

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/11/Roulette-wheel.jpg” width=”250″ height=”160″ lightbox=”on” title=”Regent’s Park raises £5,620 for The Royal Marsden Hospital Cancer Charity” align=”left” ]

LONDON, United Kingdom, 7 June, 2011: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced that its senior management team raised a total of £5,620 for The Royal Marsden Hospital Cancer Charity at the 2011 HealthInvestor Awards night at the Grosvenor House Hotel, Park Lane, London.

Daniel Oberholzer, Corporate Development Director commented: “Regent’s Park had been selected as a finalist to win two award categories: ‘Diagnostic provider of the year’ and ‘Private hospital group of the year’, and whilst these awards were won by worthy competitors, our company rose to the challenge set at the charity casino to win the largest amount of money for a nominated charity. Our team beat off competition from over 1100 dinner guests to win first prize!” He added: “It was a huge pleasure for our team to be able to make this donation to such a richly deserving charity in an allied field of medicine.”

The HealthInvestor Awards promote excellence and recognise innovation in the healthcare sector. The judges shortlist organisations that have made an outstanding contribution to the industry in 2010.

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 35,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park launches Europe’s First Relocatable Hybrid Cardiac Catheter Lab

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2013/04/GK04-Procedure-Room-View-from-Head-of-table.jpg” width=”230″ height=”150″ lightbox=”on” title=”Regent’s Park launches Europe’s First Relocatable Hybrid Cardiac Catheter Lab” align=”left” ]

Regent’s Park, an independent healthcare company specialising in the provision of infrastructure solutions to the NHS, today announced it has been awarded a contract to provide Europe’s first relocatable hybrid catheter laboratory to the Great Western Hospital in Swindon, part of the Great Western Hospitals NHS Foundation Trust (“Great Western”).

Dr. Ohri, Founder and CEO of Regent’s Park said: “It is fantastic to have won yet another competitive tender before the end of the year.” He said: “This pioneering project was executed to very strict timelines and financial constraints, making it one of our most challenging as well as rewarding cath lab projects to date.” He added: “For those unfamiliar with the terminology, a hybrid cath lab combines the advantages of a cath lab with those of an operating theatre to provide cardiologists and cardiac surgeons the opportunity to perform joint endovascular procedures.”

Dr. Ohri said: “We have taken the view that the cardiology operating arena is becoming increasingly sophisticated and standard cath labs currently do not adequately meet the demands of 21st century cardiology. Most cath labs were designed for an era of diagnostic and angioplasty procedures, however the reality is that they need to be designed and built to meet the growing demands of increasingly complex invasive cardiology – electrophysiology and ablation, pacing, cardiac devices as well as the trend to perform more endovascular procedures.” He added: “For example, there are now heart operations called transcatheter aortic valve implantations (TAVI’s), that cannot easily take place in any other environment but a hybrid cath lab. Although access for most percutaneous heart valve replacements is through the femoral artery, in some people – small, elderly women for example – that blood vessel is too small to use for access. For patients such as these, the operation can only be done by means of a subclavian or transapical approach. The latter requires about a 5 centimeter surgical incision on the side of the chest, thus demanding a hybrid operating room in addition to catheterisation. If undertaken in a standard operating room, where there would be no fixed imaging equipment, the catheter part of the operation would have to be undertaken using a mobile x-ray unit, which would involve relatively high doses of radiation and poor image quality.” He concluded: “It is understandably more expensive to build these types of cath labs, but we believe the improvement in patient care they can deliver is well worth the additional costs”.

Bryn Webber, Cardiac Services Director for Regent’s Park and project lead said:  “Moving an operating theatre into a cath lab is no easy matter. It creates a complex environment in which each piece of technology has to be carefully integrated. We undertook a series of roundtable discussions with cardiologists, cardiac surgeons, staff and our patients to find the best design solution and to answer some fundamental questions: How can adequate high-end imaging be provided, for instance, without getting in the way of surgical lights and ventilation? What sort of operating table do you install to service the needs of both open and closed surgery? What sort of space and ventilation is required for cardiovascular teams sometimes amounting to ten or more people? When the equipment for anaesthesia is added, how do you ensure that lights, monitors, tubes, movable x-ray equipment, lead protection and people do not get in each other’s way? There was the additional challenge of putting all of this into a relocatable building with integrated plant and ventilation systems, as well as designing IT, PACS and service links that could be easily plugged into any host hospital.”

Bryn Webber added: “The hybrid cath lab was built and delivered in just 12 weeks to the Great Western. The lab is about 75 square metres in size, roughy double the size of a standard cath lab, and is equipped with a brand new Siemens Artis Zee floor-mounted C-arm system that can be moved into almost any axis to provide sophisticated imaging during procedures. Around the operating environment are groups of surgical lights and monitors attached to arms extending from the ceiling that can be moved into any position manually. There are also built-in sockets for connections to medical gases, contrast injector systems, intra-aortic balloon pumps and suction. We have also thought carefully about the requirements of staff in what can be very long procedures and have incorporated a kitchenette and WC into the building as well.”

Bryn Webber finally said: “Whilst this is a very sophisticated lab, it’s real value comes from the fact that it can be easily relocated to provide instant additional capacity – it can be made operational within 2 hours of delivery, and is capable of performing a complete range of procedures – both simple and highly complex cardiovascular procedures, in a safe and very high quality environment to patients.”

Regent’s Park Heart Clinics Ltd. and Regent’s Park Cardiovascular Solutions Ltd. are independent companies dedicated to creating world-class centres for the diagnosis and treatment of heart disease. Regent’s Park develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 20,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator and pacing procedures. regent’s park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park awarded a contract to provide Managed PCI Cath Lab Services in Hertfordshire

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/08/Regents-Park-Beating-Heart.jpg” width=”300″ height=”200″ lightbox=”on” title=”Regent’s Park awarded a contract to provide Managed PCI Cath Lab Services in Hertfordshire” align=”left” ]

Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has been awarded a contract to provide a managed PCI service at Lister hospital in Stevenage, part of the East & North Hertfordshire NHS Trust.

Daniel Oberholzer, Corporate Development Director of Regent’s Park said: “We are very pleased to have been awarded this contract to provide a managed PCI service using one of our fleet of specialist modular cath labs. Our lab and full complement of staff will allow the Trust to expand its primary PCI capabilities for patients requiring urgent access to a cath lab following a heart attack.”

He added: “The award is perfectly aligned with our strategy of working with NHS hospitals to meet the challenges for expanding access to primary angioplasty services to local communities. We all look forward to the privilege of working with the cardiologists and staff at Lister Hospital.”

Regent’s Park Heart Clinics Ltd. and Regent’s Park Cardiovascular Solutions Ltd. are independent companies dedicated to creating world-class centres for the diagnosis and treatment of heart disease. Regent’s Park develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 20,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park awarded a contract to provide a PCI and Cardiac Devices Modular Cath Lab in South London

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2010/09/croydon2.jpg” width=”300″ height=”200″ lightbox=”on” title=”Regent’s Park awarded a contract to provide a PCI and Cardiac Devices Modular Cath Lab in South London” align=”left” ]
Regent’s Park Cardiovascular Solutions Ltd. (Regent’s Park), an independent healthcare company specialising in the provision of infrastructure solutions to the NHS, today announced it have been awarded a contract to provide a specialist PCI & cardiac devices modular cath lab to Croydon University Hospital in South London.

Daniel Oberholzer, Corporate Development Director of Regent’s Park said: “We are very pleased to have won this competitive tender and to break into the London cath lab arena. The award will add to our nationwide network of specialist cardiology facilities and confirm our position as the UK’s leading independent cardiology services provider. The award fits extremely well with our strategy of working with growing NHS hospitals to improve the access and quality of cardiac care to local communities. We all look forward to the privilege of working with the cardiologists and staff at Croydon University Hospital.”

Regent’s Park Heart Clinics ltd. and Regent’s Park Cardiovascular Solutions Ltd. are independent companies dedicated to creating world-class centres for the diagnosis and treatment of heart disease. Regent’s Park develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 20,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park launches a new sister company called Regent’s Park Cardiovascular Solutions Ltd.

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2010/07/rpcvslogo3d.jpg” width=”300″ height=”200″ lightbox=”on” title=”Regent’s Park launches a new sister company called Regent’s Park Cardiovascular Solutions Ltd.” align=”left” ]
Regent’s Park Heart Clinics Ltd. (Regent’s Park or RPHC), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has launched a new sister-company called Regent’s Park Cardiovascular Solutions Ltd. or ‘RPCVS’.

The new private limited company will focus on providing infrastructure solutions to assist the NHS and private healthcare sectors across the UK.

RPCVS will design, build, equip and finance specialist healthcare buildings. These will include mobile, modular and hybrid cath labs, operating theatres and recovery wards, through to multi-disciplinary imaging and diagnostic centres with MRI and CT scanners. The company will also be developing more community based cardiology facilities to better meet the needs of GP’s.

Dr. Ohri, Founder & CEO of the Regent’s Park Healthcare Group, said: “We’re planning on making a substantial investment in our current and emerging capabilities to meet the increasing demands from our customers and the changing needs of our healthcare sector.” He added: “RPCVS will complement RPHC’s core business which continues to be focused on creating cost-effective and high quality cardiovascular solutions to its customers and patients. The two companies can now offer a complete range of solutions tailor made to cardiac professionals and their departments wishing to expand their service lines or to embrace a cardiovascular partner to help them fulfill their service needs.”

Dr. Ohri said: “I believe we are entering into a new ten year cycle for cardiovascular healthcare delivery that will require all players, public and private, to radically re-think how they build and renew their service models at every level of care: primary, secondary and tertiary.” Dr. Ohri concluded: “These are exciting times that bring huge opportunities to the Regent’s Park Healthcare Group as we build our reputation as the leading independent cardiovascular service provider across the UK and further afield.”

Regent’s Park Heart Clinics Ltd. and Regent’s Park Cardiovascular Solutions Ltd. are independent companies dedicated to creating world-class centres for the diagnosis and treatment of heart disease. Regent’s Park develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 20,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park Heart Clinics Ltd. invited to speak at the 2010 Annual Acute Healthcare Conference

[frame src=http://www.rpcvs.co.uk/wp-content/uploads/2010/04/LB-logo-2010-conference-regents-park2.jpg align=”left” ]

LONDON, United Kingdom, 16 April, 2010: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced that its Chief Executive, Dr. Ohri, has been invited to speak at the 2010 Laing & Buisson Annual Acute Healthcare Conference.

The conference is to be held on Wednesday 26 May 2010 at the Radisson Blu Portman Hotel, 22 Portman Square, London W1H 9FL.

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 30,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

 

Regent’s Park announces the appointment of Dr. Peter Schofield MBChB (Hons), FRCP, MD, FACC, FESC as its Clinical Director

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2009/12/Dr.-Peter-Schofield-Clinical-Director-Regents-Park-Heart-Clinics1.jpg” align=”left” ]

LONDON, United Kingdom, 14 December, 2009: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has appointed Dr. Peter Schofield as its Clinical Director.

Dr. Schofield is currently a Consultant Cardiologist at Addenbrookes & Papworth Hospitals, Cambridge.
He was appointed a Consultant Cardiologist in 1989 and is currently the Clinical Chairman of the Anglia Cardiac Network.  The network is responsible for the strategic direction and provision of cardiac services within Cambridgeshire, Norfolk and Suffolk.

Dr. Schofield holds a National Clinical Excellence Award – currently level 10. His subspecialty interest is in percutaneous coronary intervention procedures. His experience in this area covers some 25 years of practice. In recent years, he has carried out up to 750 procedures per year with a success rate of greater than 98%.

Dr. Schofield has published over 150 research papers in peer reviewed journals.  He has also written 5 books on cardiovascular disease. His major research interest over the years has been the evaluation of new technologies in the cardiovascular field.  Most of this work has been published in peer reviewed journals. As a result of this, many techniques have now been incorporated into routine clinical practice.  

Dr. Schofield was the Secretary of the British Cardiac Society (BCS) for a period of 4 years and has been a Council Member of the British Cardiovascular Intervention Society (BCIS). He is a Fellow of the Royal College of Physicians, Fellow of the American College of Cardiology and Fellow of the European Society of Cardiology.

 “I am delighted to welcome Dr. Schofield to our company.” said Dr. Ohri, Chairman and Chief Executive Officer of Regent’s Park. “He brings immense clinical and managerial experience that will be beneficial as we continue to develop patient-focused services, grow through joint ventures and expand our business activities across the United Kingdom.”  Dr. Ohri added: “His wide ranging expertise derived from the NHS, academia and industry, as well as his strategic work at a national level with BCS and BCIS, has allowed him to understand both the complexities and challenges within the cardiovascular services sector. It means he is ideally placed to provide our company with strong clinical leadership on future cardiovascular trends, as well as the organisation and structure of next generation cardiovascular programs.”

Dr. Schofield said: “I am very pleased to become the Clinical Director of a company with such high standards for delivering quality cardiovascular care.” He added: “Regent’s Park is developing a strong reputation within the cardiovascular services sector, and its proven track record of developing cost-effective, innovative partnerships with the NHS makes it a company with excellent growth opportunities.”

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 23,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park announces the award of a contract to provide Invasive Cardiology Services at Great Western Hospitals NNS Foundation Trust

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2009/10/truck.jpg” width=”300″ height=”157″ lightbox=”on” title=”Regent’s Park announces the award of a contract to provide Invasive Cardiology Services at Great Western Hospitals NNS Foundation Trust” align=”left” ]
Regent’s Park  Announces the Award of a Contract to Provide Invasive Cardiology Services at Great Western Hospitals NHS Foundation Trust, Swindon

London, United Kingdom, 11 October, 2009: Regent’s Park Heart Clinics Ltd. & Regent’s Park Cardiovascular Solutions Ltd. (Regent’s Park), independent healthcare companies specialising in the diagnosis and treatment of heart disease, today announced they have been awarded a contract to provide invasive cardiology services at the Great Western Hospital in Swindon, part of the Great Western Hospitals NHS Foundation Trust (“Great Western”).

Dr. Ohri, Chief Executive of Regent’s Park said: “We are very pleased to have won this competitive tender following its advertisement in the Official Journal of the European Union. The award will add to our growing network of specialist cardiology facilities and confirm our position as the UK’s leading independent cardiology services provider. The award fits extremely well with our strategy of working with leading NHS hospitals to improve the access and quality of cardiac care to local communities. We all look forward to the privilege of working with the cardiologists and staff at the Great Western.”

Regent’s Park will be providing the Trust with a fully staffed mobile cardiac catheterisation laboratory – one the newest in their current fleet of labs – that will remain on site throughout the duration of the contract.

Leighton Day, Cardiology Services Manager and part of the tender assessment team at the Great Western said: “We look forward to working with Regent’s Park going forward to help develop our exciting service expansion plans at the Trust”. He added:  “They won this tender because they had an excellent track record of working with other NHS Trusts, were able to offer the latest cath lab equipment, and were more competitively priced than any of the other bidders.”

The Great Western Hospitals NHS Foundation Trust (formerly the Swindon and Marlborough NHS Trust) provides health services from two main sites – the Great Western Hospital in Swindon, which is a district general hospital, and Savernake hospital in Marlborough. The Trust employs 3,300 staff, serving a population of about 330,000 people and has an annual turnover in the region of £156 million. The Great Western Hospital opened in December 2002, replacing the Princess Margaret Hospital in old town Swindon. The hospital is a modern district general hospital with more than 600 beds and offers a range of services and facilities from a busy emergency department boasting one of the best helipads in the country, a dynamic radiology department, a birthing pool, and ample car parking. The Trust has one of the lowest MRSA infection rates in the country.

Regent’s Park Heart Clinics Ltd. and Regent’s Park Cardiovascular Solutions are independent companies dedicated to creating world-class centres for the diagnosis and treatment of heart disease. Regent’s Park develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 15,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park announces the appointment of a Director of Corporate Development

[frame src=https://www.rphc.co.uk/wp-content/uploads/2009/09/Daniel_Oberholzer1.jpg align=”left” ]

LONDON, United Kingdom, 14 September, 2009: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has appointed Daniel Oberholzer as its Director of Corporate Development.

Prior to joining Regent’s Park, Daniel worked in a variety of commercial and financial roles for HCA hospitals, the largest group of private hospitals in London and for Medical Diagnostic and Imaging, a leading provider of diagnostic and imaging services in the UK. Daniel has attained a wealth of experience in the independent cardiovascular healthcare sector, which includes experience in working with the NHS on various projects.

Daniel is well experienced in defining business system requirements, designing and delivering of solutions, as well as the implementation of consistent operational processes. He has a passion for creating high quality, value based organisations. Daniel’s responsibilities include strategy, business development and operations.

“Daniel has a strong track record of being able to help patient-focused healthcare companies grow, and I’m excited that he will bring that insight to our company,” said CEO & Chairman, Dr. Ohri. “He possesses strategic skills, leadership traits and a wealth of operational, financial, and corporate development experience that will be a tremendous benefit.”

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 22,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park announces the development of a specialist heart clinic in partnership with Addenbrooke’s Hospital, Cambridge

[frame src=https://www.rphc.co.uk/wp-content/uploads/2008/07/CHC-2013-logo.jpg align=”left” ]

LONDON, United Kingdom, 4 July, 2008: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has entered into a partnership to develop a specialist heart clinic on the grounds of Addenbrooke’s Hospital in Cambridge. 

The partnership will lead to the development of a dedicated private patient cardiology centre within Addenbrooke’s Hospital, to be called “The Cambridge Heart Clinic”. The heart clinic will be operated by Regent’s Park and will initially provide a comprehensive range of outpatient based investigations such as screening, electrocardiography, echocardiography and stress tests, as well as invasive cardiac procedures such as angiography and pacemaker insertion. Over time the heart clinic will migrate to providing percutaneous coronary intervention and cardiac electrophysiology services.

“We are extremely pleased to be entering this long-term partnership with the world-famous Addenbrooke’s Hospital,” says Dr. Ohri, Chief Executive Officer of Regent’s Park. “This reflects our largest venture with an NHS Trust since we announced our intention to partner with NHS providers to make our cardiovascular expertise available in a host of different partnership arrangements. It is the first of a series of heart clinics in our development pipeline, and is therefore an important step forward for Regent’s Park.” 

He added, “we are particularly excited about working more closely with Addenbrooke’s cardiologists and the Trust to help bring their experience and expertise to assist us in implementing clinical improvements, marketing initiatives and operating efficiencies. It will mean that private patients are assured of a first-class patient experience in a safe, high-quality environment. It also means that the Trust can re-invest surplus monies back into NHS patient care. We view this type of arrangement as important to our joint success.”

The Cambridge Heart Clinic is scheduled to open in late October 2008.
Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 12,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.